122 related articles for article (PubMed ID: 3035349)
1. The efficacy of biological response modifiers against murine cytomegalovirus infection in normal and immunodeficient mice.
Okada M; Minamishima Y
Microbiol Immunol; 1987; 31(1):45-57. PubMed ID: 3035349
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of biological response modifiers on murine cytomegalovirus infection.
Ebihara K; Minamishima Y
J Virol; 1984 Jul; 51(1):117-22. PubMed ID: 6202880
[TBL] [Abstract][Full Text] [Related]
3. The effect of biological response modifiers on chronic and latent murine cytomegalovirus infections.
Okada M; Minamishima Y
Microbiol Immunol; 1987; 31(5):435-47. PubMed ID: 2443815
[TBL] [Abstract][Full Text] [Related]
4. Role of NK cells in immunomodulator-mediated resistance to herpesvirus infection.
Kunder SC; Wu L; Morahan PS
Antiviral Res; 1993 Jun; 21(2):103-18. PubMed ID: 8393316
[TBL] [Abstract][Full Text] [Related]
5. Protective activity of the lipid A analogue GLA-60 against murine cytomegalovirus infection in immunodeficient mice.
Ikeda S; Neyts J; Matsuura M; Kiso M; Hasegawa A; Nishimura C; De Clercq E
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1399-403. PubMed ID: 8393081
[TBL] [Abstract][Full Text] [Related]
6. Increased susceptibility to cytomegalovirus infection in beige mutant mice.
Shellam GR; Allan JE; Papadimitriou JM; Bancroft GJ
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5104-8. PubMed ID: 6272291
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice.
Bukowski JF; Woda BA; Welsh RM
J Virol; 1984 Oct; 52(1):119-28. PubMed ID: 6207307
[TBL] [Abstract][Full Text] [Related]
8. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance.
Bancroft GJ; Shellam GR; Chalmer JE
J Immunol; 1981 Mar; 126(3):988-94. PubMed ID: 6257788
[TBL] [Abstract][Full Text] [Related]
9. Protection of OK-432, a Streptococcus pyogenes preparation, against lethal infection of mice with herpes simplex virus.
Harada Y; Kurokawa E; Endo H; Kimura T; Saito M; Sugawara Y; Irie H; Ito K; Fujii M; Shimizu Y
Microbiol Immunol; 1989; 33(6):467-77. PubMed ID: 2549347
[TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.
Bukowski JF; Warner JF; Dennert G; Welsh RM
J Exp Med; 1985 Jan; 161(1):40-52. PubMed ID: 2981954
[TBL] [Abstract][Full Text] [Related]
11. Host-mediated antiviral activity of Lactobacillus casei against cytomegalovirus infection in mice.
Ohashi T; Yoshida A; Minamishima Y
Biotherapy; 1988; 1(1):27-39. PubMed ID: 2484431
[TBL] [Abstract][Full Text] [Related]
12. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
Bukowski JF; Welsh RM
J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection.
McIntyre KW; Welsh RM
J Exp Med; 1986 Nov; 164(5):1667-81. PubMed ID: 3490535
[TBL] [Abstract][Full Text] [Related]
14. Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2.
Talmadge JE; Herberman RB; Chirigos MA; Maluish AE; Schneider MA; Adams JS; Philips H; Thurman GB; Varesio L; Long C
J Immunol; 1985 Oct; 135(4):2483-91. PubMed ID: 2411797
[TBL] [Abstract][Full Text] [Related]
15. Effect of Chlorella vulgaris extracts on murine cytomegalovirus infections.
Ibusuki K; Minamishima Y
Nat Immun Cell Growth Regul; 1990; 9(2):121-8. PubMed ID: 1693753
[TBL] [Abstract][Full Text] [Related]
16. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
Orange JS; Wang B; Terhorst C; Biron CA
J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
[TBL] [Abstract][Full Text] [Related]
17. Murine cytomegalovirus-inhibitory effects of ImuVert.
Sidwell RW; Smee DF; Warren RP; Huffman JH; Gilbert BJ; Burger RA; Pearson FC
Antiviral Res; 1993 Apr; 20(4):279-92. PubMed ID: 8387257
[TBL] [Abstract][Full Text] [Related]
18. The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity.
Sumaria N; van Dommelen SL; Andoniou CE; Smyth MJ; Scalzo AA; Degli-Esposti MA
Immunol Cell Biol; 2009 Oct; 87(7):559-66. PubMed ID: 19564888
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of MDP-Lys(L18), a synthetic derivative of muramyldipeptide, on murine cytomegalovirus infection.
Eizuru Y; Nakagawa N; Hamasuna R; Minamishima Y
Nat Immun; 1992; 11(4):225-36. PubMed ID: 1384831
[TBL] [Abstract][Full Text] [Related]
20. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells.
Scalzo AA; Fitzgerald NA; Wallace CR; Gibbons AE; Smart YC; Burton RC; Shellam GR
J Immunol; 1992 Jul; 149(2):581-9. PubMed ID: 1378069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
